FYI LBT's FDA approval propelled them to 400% rise and it came crashing down after some dodgy CR at the top of their SP. FDA approval is not everything as RAP needs to ensure it has commercial viability post approval.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Provides SMARTCOUGH-C May Study Update
Ann: ResApp Provides SMARTCOUGH-C May Study Update, page-108
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)